Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
PLoS One ; 17(6): e0269273, 2022.
Article in English | MEDLINE | ID: covidwho-1879320

ABSTRACT

BACKGROUND: Vaccination is the promising strategy to control the coronavirus disease 2019 (COVID-19) pandemic. However, the success of this strategy will rely mainly on the rate of vaccine acceptance among the general population. Therefore, this systematic review and meta-analysis aimed to estimate the pooled prevalence of COVID-19 vaccine acceptance and its determinants in Ethiopia. METHODS: We searched PubMed, Scopus, Google Scholar, African Journals Online, and Web of Sciences database to retrieve related articles. Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines were used for this study. Funnel plot and Eggers test were done to assess publication bias. Cochrane Q-test and I2 statistic were done to chick evidence of heterogeneity. Subgroup analysis was computed based on the study region and the study population. Data were extracted using a Microsoft Excel spreadsheet and analyzed using STATA version 14 statistical software. Weighted inverse variance random effect model was run to estimate the pooled prevalence of COVID-19 vaccine acceptance. RESULTS: A total of 12 studies with 5,029 study participants were included. The pooled prevalence of COVID-19 vaccine acceptance in Ethiopia was 51.64% (95%CI; 43.95%-59.34%). Being male (AOR = 4.46, 1.19-16.77, I2 = 88%), having secondary and above educational status (AOR = 3.97, 1.94-8.12, I2 = 69%), good knowledge (AOR = 3.36, 1.71-6.61, I2 = 93%), and positive attitude (AOR = 5.40, 2.43-12.00, I2 = 87%) were determinants of COVID-19 vaccine acceptance in Ethiopia. CONCLUSION: The pooled prevalence of COVID-19 vaccine acceptance was low. Being male, having secondary and above educational status, good knowledge, and positive attitude were the determinants of COVID-19 vaccine acceptance. High level of COVID-19 vaccine acceptance among the general population is crucial to achieve herd immunity in the community. Therefore, policymakers, vaccine campaign program planners, and stakeholders should target to improve public awareness of vaccination that enhances vaccine acceptance and in turn helps to control the pandemic.


Subject(s)
COVID-19 Vaccines , COVID-19 , COVID-19/epidemiology , COVID-19/prevention & control , Ethiopia/epidemiology , Female , Humans , Male , Pandemics/prevention & control , Prevalence
2.
Reprod Health ; 18(1): 246, 2021 Dec 13.
Article in English | MEDLINE | ID: covidwho-1571836

ABSTRACT

BACKGROUND: World health organization (WHO) defines intimate partner violence (IPV) is physical, sexual, or emotional abuse by an intimate partner or ex-partner or spouse to a woman. From all forms of violence, ~ 1.3 million people worldwide die each year, accounting for 2.5% of global mortality. During the COVID-19 crisis, control and prevention measures have brought women and potential perpetrators together which increase the risk of IPV. Therefore, this study was aimed to assess the magnitude and associated factors of IPV against women during COVID-19 in Ethiopia. METHODS: Community based cross-section study was employed among 462 reproductive-age women to assess IPV and associated factors during COVID-19 pandemic. To select study participants one-stage cluster sampling technique was used. The data were entered into Epi data version 4.2 and exported to SPSS for analysis. Bivariate and multivariate analysis was used to check the association of dependent and independent variables and statistical significance was declared at P < 0.05. RESULT: A total of 448 study subjects were responded making a response rate of 96.97%. Two- third (67.6%) of the respondent's age range was between 20 and 29 years. All of the participants heard about the pandemic of COVID-19 at the time of onset. The lifetime and the last twelve months prevalence of women with IPV was 42.19% and 24.11%, respectively. About 58 (12.9%) had experienced all three types of violence. Participants age ≥ 35 (AOR = 2.02; 95% CI: 1.99-4.29), rural residence (AOR = 3.04; 95% CI: 2.59-6.25), husband's educational status of diploma and above (AOR = 0.35; 95% CI: 0.14-0.83), COVID-19 pandemic (AOR = 4.79; 95% CI: 1.13-6.86), and low social support (AOR = 3.23; 95% CI: 1.99-6.23) were independent predictors. CONCLUSIONS: In this study two in five women undergo one type of violence in their lifetime. The occurrence of the COVID-19 pandemic has its impact on violence. Age ≥ 35, rural residence, husband's educational status of diploma and above, history of child death, COVID-19 pandemic, and low social support were independent predictors of violence. This implies insight to concerned bodies like policymakers and stakeholders to design appropriate policies to avert this magnitude and making zero tolerance for violence in society.


Intimate partner violence is physical, sexual, or emotional abuse by an intimate partner or ex-partner or spouse to a woman. Community based cross-section study was employed among 462 reproductive-age women to assess the magnitude and associated factors of IPV against women during COVID-19 in Ethiopia. Bivariate and multivariate analysis was used to check the association of dependent and independent variables and statistical significance was declared at P < 0.05. A total of 448 study subjects were responded making a response rate of 96.97%. In this study two in five women undergo one type of violence in their lifetime. The occurrence of the COVID-19 pandemic has its impact on violence. Age ≥ 35, rural residence, husband's educational status of diploma and above, history of child death, COVID-19 pandemic and low social support were independent predictors of violence. This sparks light to concerned bodies like policymakers and stack holders to design appropriate policies to avert this magnitude and making zero tolerance for violence in society.


Subject(s)
COVID-19 , Intimate Partner Violence , Adult , Ethiopia/epidemiology , Female , Humans , Pandemics , Prevalence , Risk Factors , SARS-CoV-2 , Sexual Partners , Young Adult
3.
Infect Drug Resist ; 14: 2015-2025, 2021.
Article in English | MEDLINE | ID: covidwho-1256164

ABSTRACT

INTRODUCTION: Although many vaccines are in development and clinical trials, and at least seven vaccines have been distributed worldwide, the world has faced a huge challenge in line with the willingness to accept a COVID-19 vaccine in a different country including Ethiopia. However, no study has been conducted on the knowledge, attitudes, acceptance, and determinates of COVID-19 vaccine acceptance in Ethiopia. Therefore, this study was aimed to investigate the knowledge, attitudes, acceptance, and determinants of acceptance of the COVID-19 vaccine among the adult population in Ethiopia. METHODS: A community-based cross-sectional study was conducted among 492 study participants from March 1 to March 15, 2021. A multistage sampling technique was used to recruit study participants. Six skilled and qualified data collectors had participated to gather the data using a pretested structured-administered questionnaire. A multivariable logistic regression model was used to identify factors associated with the acceptance of the COVID-19 vaccine. P-value <0.05 was considered to indicate statistically significant association. RESULTS: This study revealed that the level of good knowledge, positive attitude and intention to accept the COVID-19 vaccine were 74%, 44.7%, and 62.6%, respectively. Moreover, having an age ≥46 years with an adjusted odds ratio of 2.36 [95% CI, 1.09-5.39], attended secondary and above education adjusted odds ratio 2.59 [95% CI, 1.52-4.39], having a chronic disease adjusted odds ratio of 3.14 [95% CI, 1.21-8.14], and having good knowledge about COVID-19 vaccine adjusted odds ratio 2.59 [95% CI, 1.67-4.02] were significantly associated with COVID-19 vaccine acceptance. CONCLUSION: In this study, the level of good knowledge, positive attitude, and intention to accept the COVID-19 vaccine were 74%, 44.7%, and 62.6%, respectively. Thus, health education and communication from government sources are very crucial methods to alleviate the negative attitude of the COVID-19 vaccine.

SELECTION OF CITATIONS
SEARCH DETAIL